Pediatric Endocrinology

Latest News

Effects of a Gluten-Free Diet in Patients With Type 1 Diabetes and Asymptomatic Celiac Disease

By

Rose Reeb

In individuals with type 1 diabetes who test positive for asymptomatic celiac disease, a gluten-free diet may increase postprandial glycemic levels.

Bariatric Surgery Outcomes Similar Regardless of Age at Obesity Onset

The treatment benefits of bariatric surgery in adults are similar regardless of early- or adult-onset obesity.

Obesity and Type 2 Diabetes Predispose Adolescents to Accelerated Vascular Aging

By

Amit Akirov, MD

Adolescents with obesity or type 2 diabetes are at increased risk for progression of cardiovascular risk factors and accelerated early vascular aging.

Setmelanotide Granted Priority Review for Rare Genetic Obesity Disorders

By

Brian Park, PharmD

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for setmelanotide for the treatment of pro-opiomelanocortin (POMC) deficiency obesity and leptin receptor (LEPR) deficiency obesity.

Dolutegravir Improves Lipid Concentrations but Increases Trunk Fat in Youths With HIV

By

Dibash Kumar Das, PhD

Dolutegravir-based regimen may lead to significant improvement in lipids blood concentration, but relevant increases in trunk fat without alterations of body mass index.

Upward Income Mobility Linked to Worse Cardiometabolic Health

Upward income mobility is associated with lower perceived stress and fewer depressive symptoms but with higher rates of metabolic syndrome.

Healthcare Systems in New York City Implement Joint Telehealth Program for Children With Obesity During the COVID-19 Pandemic

By

Amit Akirov, MD

Healthcare systems in New York City have partnered to support vulnerable children with obesity using a telehealth weight management program.

Children With HIV Receiving ART May Have Deficits in Bone Architecture and Strength

By

Zahra Masoud

Children living with HIV demonstrate deficits in bone architecture and reductions in bone strength, compared with children without HIV.

Leuprolide Acetate Approved for Central Precocious Puberty

By

Diana Ernst, RPh

The FDA has approved Fensolvi (leuprolide acetate; Tolmar Pharmaceuticals) for the treatment of pediatric patients 2 years of age and older with central precocious puberty.

Encouraging Bone-Strengthening Behaviors in Children May Prevent Osteoporosis in Adulthood

By

Endocrinology Advisor Contributing Writer

Researchers presented the outcomes from a 2-year intervention that included bone-strengthening physical activity and dietary behaviors of children attending after-school programs in the United States.

The Renal-Bone Axis and ART in Adolescents and Elderly With HIV

By

Zahra Masoud

Particular antiretroviral therapy (ART) regimens may decrease bone mass density (BMD) in both adolescents and older people living with HIV (PWHIV).